SCHEMBL21959664

SCHEMBL21959664

CNn1ccc(C(C)C)cc1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.37
PTGS2 P35354 1/20 0.36
TYR P14679 3/20 0.35
HDAC4 P56524 2/20 0.35
HDAC8 Q9BY41 2/20 0.35
CYP3A4 P08684 2/20 0.35
RNASEH1 O60930 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MDM4 O15151 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
CA5A P35218 1/20 0.35
HTT P42858 1/20 0.35
MDM2 Q00987 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL799134 0.74 PTGS2 (0.39) IDH1PTGS2TYRHDAC4HDAC8
SCHEMBL21998501 0.72 IDH1 (0.42) IDH1PTGS2TYRHDAC4HDAC8
SCHEMBL11317932 0.72 PTGS2 (0.49) IDH1PTGS2TYRHDAC4HDAC8
SCHEMBL26007774 0.69 PTGS2 (0.46) IDH1PTGS2TYRHDAC4HDAC8
SCHEMBL26005499 0.69 PTGS2 (0.68) IDH1PTGS2TYRHDAC4HDAC8
SCHEMBL26005494 0.69 PTGS2 (0.54) IDH1PTGS2TYRHDAC4HDAC8
SCHEMBL889379 0.69 MGLL (0.48) TYRRNASEH1KDM4EALDH1A1ALOX15
SCHEMBL14501877 0.69 ACACB (0.40) IDH1PTGS2TYRHDAC4HDAC8
SCHEMBL22214031 0.68 PTGS2 (0.38) IDH1PTGS2TYRHDAC4HDAC8
SCHEMBL4627329 0.68 SMN1; SMN2 (0.55) IDH1KDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020079106-A1 CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-04-23 WO disclosed